BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 542934)

  • 1. The released proteins from avian thrombocytes.
    Wachowicz B; Krajewski T
    Thromb Haemost; 1979 Dec; 42(4):1289-95. PubMed ID: 542934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects on platelet function of removal of platelet sialic acid by neuraminidase.
    Greenberg J; Packham MA; Cazenave JP; Reimers HJ; Mustard JF
    Lab Invest; 1975 Apr; 32(4):476-84. PubMed ID: 1127870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet antiplasmin: its extrusion during the release reaction, subcellular localization, characterization, and relationship to antiheparin in pig platelets.
    Joist JH; Niewiarowski S; Nath N; Mustard JF
    J Lab Clin Med; 1976 Apr; 87(4):659-69. PubMed ID: 131845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets.
    Koda M; Banno Y; Naganawa T
    Platelets; 2005 Dec; 16(8):482-91. PubMed ID: 16287615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA).
    Chen R; Liang N
    Cell Biol Int; 1998; 22(6):429-35. PubMed ID: 10328851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clq inhibition of the interaction of collagen with human platelets.
    Cazenave JP; Assimeh SN; Painter RH; Pachham MA; Mustard JF
    J Immunol; 1976 Jan; 116(1):162-3. PubMed ID: 1245737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UV light-induced changes in washed pig platelets.
    Krajewski T; Wachowicz B; Bończak M; Pietrucha T
    Acta Biochim Pol; 1985; 32(2):155-62. PubMed ID: 4036449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of bovine platelet cationic proteins which inhibit the surface-mediated activation of factor XII and prekallikrein.
    Kodama K; Kato H; Iwanaga S
    J Biochem; 1985 Jan; 97(1):139-51. PubMed ID: 3158644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low molecular weight and protein dinitrosyl complexes of non-heme iron as inhibitors of platelet aggregation].
    Kuznetsov VA; Mordvintsev PI; Dank EKh; Iurkiv VA; Vanin AF
    Vopr Med Khim; 1988; 34(5):43-6. PubMed ID: 2851211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditions influencing platelet lysis.
    Kinlough-Rathbone RL; Chahil AMAR ; Packham MA; Mustard JF
    Lab Invest; 1975 Mar; 32(3):352-8. PubMed ID: 1123914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathways responsible for platelet hypersensitivity in rats with diabetes. II. Spontaneous diabetes in BB Wistar rats.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):154-8. PubMed ID: 3080539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on pig blood platelet responses to peroxynitrite action.
    Nowak P; Wachowicz B
    Platelets; 2001 Sep; 12(6):376-81. PubMed ID: 11672476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actin-binding ability of the protein with the molecular weight of 47,000 phosphorylated during platelet activation.
    Sasaki A; Hiyoshi M; Hashimoto K; Im T; Tatsumi N; Okuda K
    Biochem Int; 1989 Oct; 19(4):737-44. PubMed ID: 2619746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct electrochemical measurement of nitric oxide released from human platelets.
    Malinski T; Radomski MW; Taha Z; Moncada S
    Biochem Biophys Res Commun; 1993 Jul; 194(2):960-5. PubMed ID: 8343175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo functions of thrombin-treated platelets.
    Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
    Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
    Rendu F; Bachelot C; Molle D; Caen J; Guez D
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipids released from activated platelets improve platelet aggregation and endothelial cell migration.
    Xiao H; Siddiqui RA; Al-Hassani MH; Sliva D; Kovacs RJ
    Platelets; 2001 May; 12(3):163-70. PubMed ID: 11304418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.